Acute Hepatitis C (HCV) Infections: Safety and Efficacy of Glecaprevir(GLE)/Pibrentasvir (PIB) 8-Week Treatment. Protocol No: M20-350.

Grants and Contracts Details

StatusFinished
Effective start/end date4/25/22 → 4/24/23

Funding

  • AbbVie Incorporated: $23,309.00